bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.750
+0.080 (4.79%)
At close: Jun 1, 2026, 4:00 PM EDT
1.742
-0.008 (-0.49%)
After-hours: Jun 1, 2026, 6:59 PM EDT

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
85141413-
Market Cap Growth
43.80%-62.54%2.63%2.98%--
Enterprise Value
6.21-0.3613.8712.112.250
Last Close Price
1.751.1827.3044.1048.00-
PS Ratio
1.400.861.515.452792.02-
PB Ratio
2.150.735.452.841.21-
P/TBV Ratio
1.290.284.242.650.65-
EV/Sales Ratio
1.10-0.061.484.78468.06-
EV/EBITDA Ratio
-0.04----
EV/EBIT Ratio
-0.03----
EV/FCF Ratio
-0.04----
Debt / Equity Ratio
0.300.110.310.230.02-0.96
Net Debt / Equity Ratio
-0.47-0.730.15-0.26-1.01-0.63
Net Debt / EBITDA Ratio
0.160.53-0.050.162.79-4.54
Net Debt / FCF Ratio
0.160.56-0.050.212.60-4.88
Asset Turnover
0.600.711.270.250.000
Inventory Turnover
57.63104.17259.63144.930.17-
Quick Ratio
1.192.410.721.6210.030.10
Current Ratio
1.362.600.871.7710.500.11
Return on Equity (ROE)
-290.34%-301.83%-242.44%-99.84%2319.94%55.56%
Return on Assets (ROA)
-121.81%-120.65%-121.37%-77.95%-58.82%-275.95%
Return on Invested Capital (ROIC)
-297.51%-252.20%-192.72%-305.01%-68.59%-20.81%
Return on Capital Employed (ROCE)
-180.45%-184.46%-190.85%-93.71%1477.98%19.56%
Buyback Yield / Dilution
-492.83%-325.83%-38.61%-94.43%-67.83%-0.31%
Total Shareholder Return
-492.83%-325.83%-38.61%-94.43%-67.83%-0.31%
SEC Filings: 10-K · 10-Q